Potentiation of lonidamine and diazepam, two agents acting on mitochondria, in human glioblastoma treatment

Journal of the National Cancer Institute

Volumn 90, Issue 18, 1998, Pages 1400-1406

  Miccoli, Laurent ^a   Poirson Bichat, Florence ^a   Sureau, Franck ^b   Bras Gonçalves, Rui ^a   Bourgeois, Yveline ^a   Dutrillaux, Bernard ^a   Poupon, Marie France ^a,b,c   Oudard, Stéphane ^a  

^a INSTITUT CURIE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; DIAZEPAM; DNA FRAGMENT; GLUCOSE; HEXOKINASE; LONIDAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CELL CYCLE; CELL METABOLISM; CELL PH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG POTENTIATION; ENERGY METABOLISM; FEMALE; GLIOBLASTOMA; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; MEMBRANE FLUIDITY; MOUSE; NONHUMAN; NUDE MOUSE;

EID: 0032537956     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.18.1400     Document Type: Article

References (46)

1. Furnari FB, Huang HJ, Cavenee WK. Genetics and malignant progression of human brain tumours. Cancer Surv 1995;25:233-75.
2. Delattre JY, Uchuya M. Radiotherapy and chemotherapy for gliomas. Curr Opin Oncol 1996; 8:196-203.
3. Burk D, Woods M, Hunter J. On the significance of glucolysis for cancer growth, with special reference to Morris rat hepatomas. J Natl Cancer Inst 1967;38:839-63.
4. Hume DA, Weidermann MJ. Role and regulation of glucose metabolism in proliferating cells. J Natl Cancer Inst 1979;62:3-8.
5. Oudard S, Poirson F, Miccoli L, Bourgeois Y, Vassault A, Poisson M, et al. Mitochondria-bound hexokinase as target for therapy of malignant gliomas. Int J Cancer 1995;62:216-22.
6. Floridi A, Paggi MG, Marcante ML, Silvestrini B, Caputo A, DeMartino C. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst 1981;66: 447-9.
7. Floridi A, Paggi MG, D'Atri S, DeMartino C, Marcante ML, Silvestrini B, et al. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res 1981; 41:4661-6.
8. Fanciulli M, Valentini A, Bruno T, Citro G, Zupi G, Floridi A. Effect of the antitumor drug lonidamine on glucose metabolism of adriamycin-sensitive and -resistant human breast cancer cells. Oncol Res 1996;8:111-20.
9. Floridi A, Lehninger AL. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch Biochem Biophys 1983; 226:73-83.
10. Gadducci A, Brunetti I, Muttini MP, Fanucchi A, Dargenio F, Giannessi PG, et al. Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer. Eur J Cancer 1994;30A:1432-5.
11. Ben-Horin H, Tassini M, Vivi A, Navon G, Kaplan O. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies. Cancer Res 1995; 55:2814-21.
12. Miccoli L, Oudard S, Sureau F, Poirson F, Dutrillaux B, Poupon MF. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J 1996;313: 957-62.
13. Linden M, Gellerfors P, Nelson BD. Pore protein and the hexokinase-binding protein from the outer membrane of rat liver mitochondria are identical. FEBS Lett 1982;141:189-92.
14. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc Natl Acad Sci U S A 1992;89:3170-4.
15. Wang JK, Morgan JI, Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc Natl Acad Sci U S A 1984; 81:753-6.
16. Wang JK, Morgan JI, Spector S. Differentiation of Friend erythroleukemia cells induced by benzodiazepines. Proc Natl Acad Sci USA 1984;81:3770-2.
17. Carayon P, Portier M, Dussossoy D, Bord A, Petitpretre G, Canat X, et al. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 1996;87:3170-8.
18. Miettinen H, Kononen J, Haapasalo H, Helen P, Sallinen P, Harjuntausta T, et al. Expression of peripheral-type benzodiazepine receptor and diazepam-binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res 1995;55:2691-5.
19. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity [3H]diazepam binding. Proc Natl Acad Sci U S A 1977;74:3805-9.
20. Gross JL, Behrens DL, Mullins DE, Kornblith PL, Dexter DL. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res 1988;48:291-6.
21. Oudard S, Arvelo F, Miccoli L, Apiou F, Dutrillaux AM, Poisson M, et al. High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss. Br J Cancer 1996;74:839-45.
22. Demarcq C, Bastian G, Remvikos Y. BrdUrd/ DNA flow cytometry analysis demonstrates cis-diamminedichloroplatinum (II)-induced multiple cell-cycle modifications on human lung carcinoma cells. Cytometry 1992;13: 416-22.
23. Straume M, Liman BJ. Equilibrium and dynamic bilayer structural properties of unsaturated acyl chain phosphatidylcholine-cholesterol-rhodopsin recombinant vesicles and rod outer segment disk membranes as determined from higher order analysis of fluorescence anisotropy. Biochemistry 1988;27: 7723-33.
24. Miccoli L, Szczepaniak C, Dumas D, Savonniere S, Muller S, Carre MC, et al. Interaction of a phosphatidylcholine derivative of 1,6-diphenyl-1,3,5-hexatriene (DPH) with intact living cells: steady state fluorescence polarization and phase fluorometry studies. J Fluoresc 1993;3:251-5.
25. Flagiello D, Poupon MF, Cillo C, Dutrillaux B, Malfoy B. Relationship between DNA methylation and gene expression of the HOXB gene cluster in small cell lung cancers. FEBS Lett 1996;380:103-7.
26. Shih SC, Stutman O. Cell cycle-dependent tumor necrosis factor apoptosis. Cancer Res 1996;56:1591-8.
27. Marangos PJ, Patel J, Boulenger JP, Clark-Rosenberg R. Characterization of peripheral-type benzodiazepine binding sites in brain using [3H]Ro 5-4864. Mol Pharmacol 1982;22: 26-32.
28. Seksek O, Henry-Toulme N, Sureau F, Bolard J. SNARF-1 as an intracellular pH indicator in laser microspectrofluorometry: a critical assessment. Anal Biochem 1991;193:49-54.
29. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979;18:2210-8.
30. Poupon MF, Arvelo F, Goguel AF, Bourgeois Y, Jacrot M, Hanania N, et al. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J Natl Cancer Inst 1993;85:2023-9.
31. Friedman HS, Johnson SP, Dong QD, Schold SC, Rasheed BK, Bigner SH, et al. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res 1997;57:2933-6.
32. Paggi MG, Carapella CM, Fanciulli M, Del Carlo C, Giorno S, Zupi G, et al. Effect of lonidamine on human malignant gliomas: biochemical studies. J Neurooncol 1988;6:203-9.
33. Teicher BA. Lonidamine: in vitrolin vivo correlations. Eur J Cancer 1994;30A:1411-3.
34. Malorni W, Arancia G, DeMartino C. On the mechanism of action of lonidamine: a study on human erythrocyte membrane. Exp Mol Pathol 1988;49:361-7.
35. Rubin LL, Philpott KL, Brooks SF. The cell cycle and cell death. Curr Biol 1993;3:391-4.
36. Del Bufalo D, Biroccio A, Soddu S, Laudonio N, D'Angelo C, Sacchi A, et al. Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene. J Clin Invest 1996; 98:1165-73.
37. Strittmatter WJ, Hirata F, Axelrod J, Mallorga P, Tallman JF, Henneberry RC. Benzodiazepine and β-adrenergic receptor ligands independently stimulate phospholipid methylation. Nature 1979;282:857-9.
38. Krueger KE. Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim Biophys Acta 1995;1241:453-70.
39. Papadopoulos V, Guarneri P, Krueger KE, Guidotti A, Costa E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci U S A 1992;89:5113-7.
40. Pawlikowski M, Kunert-Radek J, Radek A, Stepien H. Inhibition of cell proliferation of human gliomas by benzodiazepines in vitro. Acta Neurol Scand 1988;77:231-3.
41. Black KL, Ikezaki K, Santori E, Becker DP, Vinters HV. Specific high-affinity binding of peripheral benzodiazepine receptor ligands to brain tumors in rat and men. Cancer 1990;65: 93-7.
42. Ikezaki K, Black KL. Stimulation of cell growth and DNA synthesis by peripheral benzodiazepine. Cancer Lett 1990;49:115-20.
43. Saano V. Effects of peripherally acting benzodiazepines on cell growth and differentiation. In Giesen-Crouse E, ed. Peripheral benzodiazepine receptors. London: Academic Press; 1993, P. 111-21.
44. Bond AJ, Hailey DM, Lader MH. Plasma concentrations of benzodiazepines. Br J Clin Pharmacol 1977;4:51-6.
45. Greenblatt DJ, Allen MD, MacLaughlin DS, Harmatz JS, Shader RI. Diazepam absorption: effect of antacids and food. Clin Pharmacol Ther 1978;24:600-9.
46. Dasberg H. The effect of daily oral dosage of diazcpam, plasma concentrations and metabolic clearance of diazepam and demethyldiazepam on various constituents of the acute clinical anxiety syndrome. Psychother Psychosom 1974;24:113-8.